A recently introduced assay of cell mediated immunity and humoral inhibitory factors has been evaluated in colorectal cancer patients. Using a perchloric acid extract of adenocarcinoma of the large bowel as antigen, 16/27 patients with colorectal cancer had significant cellular reactivity when their separated peripheral leucocytes were tested in homologous AB serum. In autologous serum only 7/27 had significant reactivity; 6/20 patients with a variety of other malignancies showed sensitization to the colorectal antigen preparation.
In vitro techniques for assessing im-human malignancies (Maluish anld Hallimunological reactivity have facilitated day, 1974) . the study of the immune response to The principle of the test is that when human cancer and of factors which specifically sensitized lvmphocytes are modify its expression. Such information incubated with the antigens, a lymphokine is of much more than theoretical imporis released which decreases the normal tance as it could provide guidelines for tendency of leuocytes to adhere to a planning suitable immunotherapy or moni-glass surface. This is analogous to the toring the post-operative clinical course of macrophage migration system in which a patients.
product of antigen lymphocyte interaction Lymphocyte cytotoxicity (Hellstr0m causes inhibition of macrophage migration. et al., 1971a) , lymphocyte transformation
To date the LAI test has been used (Vanky et al., 1971) and leucocyte migraonly to investigate small groups of tion inhibition techniquLes (Anderson et al., patients with a specific cancer. The 1970; Guillou and Giles, 1973) have been present study was an attempt to evaluate used to show specific cell mediated imthis potentially useful test in a group of munity to tumour associated antigens in a 27 patients with colorectal cancer. variety of human malignancies. These tests are, however, time consuming, may require complex equipment and are often PATIENTS AND METHO1)S difficult to interpret.
Twenty-seven patients (mean age 656 Recently, the leucocyte adherence years) with primary adenocarcinoma of the inhibition (LAI) test has been described bv large bowel were studied pre-operatively. Halliday, Maluish and Isbister (1974) Isbister, 1974b ) and then adapted for resected adenocarcinomiata of large bowel was prepared after the method of Freed and American Corporation). After a further Taylor (1972) . None of the tumours used for 60 min incubation, the nucleated cells in a this extract were autochthonous with respect predetermined pattern of squares (16 squares/ to the patients studied. The tumour extract haemacytometer) were counted. The coverwas sterile on culture and furthermore an slips were then floated off and slides subjected antiserum raised against the extract failed to to a gentle washing procedure; the remaining, agglutinate the common enteric bacteria. adherent cells were then counted in the same As used in the LAI test this extract contained squares. 10 pg protein/ml (Kjeldahl).
The mean percentage adherence for each The technique of the LAI test was mixture was determined and a leucocyte essentially as originally described (Halliday adherence index calculated. et al., 1974a) . Leucocytes were obtained by Leucocyte adherence index sedimentation for 1 h at 370C from heparinized blood, any remaining red cells being Mean % adherence with antigen lysed by brief treatment with 0 15mol/I -Mean % without antigen ammonium chloride. After washing, the leucocytes were finally resuspended to a RESULTS concentration of 2 x 107/ml in tissue culture The mean percentage adherence for medium 199 (Wellcome) with 10% foetal calf each mixture and the leucocyte adherence serum added.
Equal volumes (0.05 ml) of the leucocyte indices for tle control subjects, colorectal suspension, tumour extract (when required) and other malignancies are shown in and undiluted pooled AB or autologous serum Tables I, II and III respectively. were mixed with TC 199 + 10% foetal calf
The control subjects exhibited little or serum, to give a final volume of 0-2 ml. Each no reduced adherence in the presence of of the mixtures was set up in duplicate. The the tumour extract either in homologous tubes were randomized, coded and then AB serum (mean index 1 024 1 0-0547 s.d.) incubated at 37°C for 30 min with constant or autologous serum (mean index 1-0421 mixing. In view of the short incubation time or0autologous s (mean nd 1igniin this assay, antibiotics were not added to ±icant d.). Asthee was noasgni the culture medium. ficant difference between the healthy Leucocyte adherence was then deter-subjects and the patients with benign mined by introducing each mixture into the disease, they have been treated as one 2 chambers of a haemacytometer (Optical group. No nonspecific or toxic effects of the tumour extract were apparent in any serum. The patients showing the sensitiof these tests. zation in this group had metastatic cancer Therefore, in this study, significantly Of the breast, lung, stomach, rectal reduced leucocyte adherence in the pres-melanoma (2) or biliary tracts. Patients ence of the tumour extract is said to have without metastases were uniformly n-egaoccurred when the index falls below the tive. 95%/ confidence limits (mean -2 s.d.) DSUSO calculated from all the control subject Dsuso observations. The results obtained in AB This study has confirmed that the serum are shown in Fig.   0 and those in interaction between human leucocytes autologous serum in Fig. 2 . from patients with colorectal cancer and In the patients with colorectal cancer an extract of pooled colorectal tumours of all stages 16/27 (59-25%) showed a sigcauses a reduced adherence of the cells to nificantly reduced index in homologous a glass surface. This reduced adherence AB serum, whereas in autologous serum does not appear to be due to toxicity of only 7 (26%) showed a significantly reduced the tumour extract since adherence of the index. Of the 20 patients with other control subjects' leucocytes was not malignancies, 6 (30%/) showed a signi-affected. Similarly, as 4 multiparous ficantly reduced index in homologous AB female control subjects showed no reduced serum and 3 (15%) in their autologous adherence, presensitization to alloantigens seems unlikely. As the assay mixtures (Maluish and Halliday, 1974) . In our were incubated only for a short time, in experience the tedious visual cell counting vitro sensitization by histocompatibility and technical dexterity necessary for antigens possibly present in the extracts consistent results might limit its usefulcan be excluded.
ness. The modification of the test by a Unfortunately the LAI test as per-radioisotope technique, recently described formed here appears to be of little use in by Peirce and Devald (1974) in animals, the positive diagnosis of large bowel could overcome these difficulties if succancer since only 16 of the 27 patients cessfully applied to man. studied exhibited significant reactivity to In this study the tumour antigen prepthe colorectal tumour extract. A different aration was extracted with perchloric type of extract may increase the sensi-acid, an established method for preparing tivity but it is of interest that similar carcinoembryonic antigen (CEA). Indeed, proportions of patients are reported to our extract has been shown to contain show sensitization to tumour associated CEA, among other antigens, by the use of antigens in large bowel malignancy and heterologous antiserum and a purified other cancers by the leucocyte migration CEA preparation (Medical Research technique (Andersen et al., 1970; Guillou Council, CEA C73/601) . The adherence and Giles, 1973) .
inhibition was specific for patients with No difference in reactivity in homotumours but not organ specific. The logous AB serum was seen between other carcinomata which were reactive patients whose tumours were locally con-were of types which can produce elevated fined (Dukes Stage A, B and C) and those serum CEA levels (Pusztaszeri and Mach, with distant spread (Stage D). This 1972). It is of interest to speculate on its clinical-pathological staging, although immunogenic role, although Lejlenyi, useful, probably does not truly represent Freedman and Gold (1971) found no the natural history of the disease. Howevidence for a cell mediated immune ever, 4/4 with histologically de-differenreaction to purified CEA using a lymphotiated tumours showed reactivity, 6/11 cyte transformation technique. Hellwith moderately differentiated tumours strom, Hellstrom and Shepard (1970) and 6/12 with well differentiated growths. demonstrated that lymphocytes from A humoral inhibitory effect of auto-patients with carcinoma of the colon, logous sera was present in 10/16 patients which reacted specifically with colon who showed reactivity when tested in cancer cells in vitro, were also cytotoxic homologous AB serum. This is analogous to foetal gut and liver epithelial cells; to the serum blocking factors reported also, a delayed skin reaction to extracts of using the lymphocyte cytotoxicity techfoetal human gut tissue containing CEA niques (Hellstrom et al., 1971b) and might was found in patients with carcinoma of represent one means by which the cellular the colon and rectum (Hollinshead et al., immunological effects of sensitized leuco-1970), however purified CEA elicited no cytes might be inhibited in vivo in the skin reaction in the one patient tested. cancer patient. In our opinion, it is as an The relationship between embryonic assay for serum blocking that the LAI macromolecules found in tumour tissue test has its greatest potential use, par-and antigens involved in anti-tumour ticularly in sequential studies of post-immunity still remain to be resolved. excision patients, as the appearance of blocking factors is reported to herald
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